European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Health

AskBio and Touchlight Restructure Joint Venture

by Marie Weil
February 9, 2022
A A
Share on LinkedinShare on Twitter

Restructuring Provides Parallel Rights to Manufacture and Sell doggybone DNA (dbDNA™) into the AAV market as Independent CDMO Businesses / AskBio Secures 100% Ownership of TAAV Manufacturing Solutions, SL to Manufacture AAV doggybone DNA (dbDNA) Technology from San Sebastian, Spain / Touchlight to Commence Independent AAV dbDNA Manufacture Through Its Existing CDMO Operation in Hampton, United Kingdom

Research Triangle Park, N.C. and Hampton, UK – 8 February 2022 – Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, and Touchlight, a biotechnology company pioneering enzymatic DNA production, have announced a revised structure to their former joint venture, Touchlight AAV.

Under the revised arrangement implemented on 1 February 2022, both parties benefit fromco-exclusive rights to independently supply the Adeno-Associated Virus (AAV) market with doggybone DNA (dbDNA™) through their respective independently owned Contract Development and Manufacturing Organisations (CDMO).

Additionally, AskBio has secured 100 percent ownership of the San Sebastian manufacturing site for its production of research, clinical and commercial AAV dbDNA. It will be operated through the former Touchlight AAV organization, which will be rebranded and operate as TAAV, as part of the restructure. TAAV will retain its right to manufacture AAV dbDNA both for AskBio’s internal product development pipeline as well as continuing to provide AAV dbDNA to third-party customers from their new, recently completed state-of-the-art facility in San Sebastian, Spain.

Through the transaction, Touchlight regains co-exclusive rights to manufacture and sell its proprietary technology, dbDNA for AAV production.

Touchlight DNA Services, the CDMO arm of the Touchlight group, supplies services, development and GMP materials across viral vectors, cell therapy, mRNA and DNA vaccines, which now expands its offering into the AAV market.

Demand for dbDNA has grown rapidly in the last year and the technology promises to revolutionise how genetic medicine is developed and manufactured. As a result of these transactions, both organizations expect continued expansion and significant growth of their provision of dbDNA to the AAV market.

dbDNA is a linear, double stranded, covalently closed DNA molecule which is produced in an enzymatic manufacturing process. It has the potential to enable faster, safer and more scalable DNA production than other traditional methods without contamination of the plasmid DNA backbone.

Financial details of the agreement are not disclosed.

Tags: < Invest

Related Industries

Health

Supporting the frontlines of Irish healthcare with AWS InCommunities

March 24, 2023
Health

Interview with Mr. Sébastien Huron, CEO, Virbac group

March 6, 2023
Health

Bayer driving innovation in radiology with new research across the portfolio presented at ECR

February 23, 2023
Health

Philips recognized as top innovator for 10th consecutive year

February 17, 2023
Health

Bayer completes acquisition of Blackford Analysis Ltd.

February 14, 2023
Health

Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio

January 25, 2023

OPPO Pledges Carbon Neutrality Across its Operations by 2050 at MWC 2023

March 2, 2023

...

Danish Carlsberg brewery saves 1 billion litres of water with new technology

March 23, 2023

...

ELC Partners with boom! to Empower Women in Supply Chain in the UK and Worldwide

March 7, 2023

...

Deutsche Post DHL Group and Poste Italiane announce a strategic partnership in the international parcel market

March 11, 2023

...

European Corporate Development & Strategy Awards

March 9, 2023

...

Valeo receives an Innovation award for EverguardTM, the next generation wiper blade

March 24, 2023

...

Harnessing the power of plants to decarbonise our data centres

March 21, 2023

...

Carlsberg Group appoints new Chief Executive Officer

March 17, 2023

...

default

Voith Hydro opens new center of competence for generator components

March 8, 2023

...

BASF advances innovation pipeline with integrated solutions to accelerate agriculture’s transformation

March 16, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist